hims and hers tirzepatide Zepbound (Tirzepatide) DIRECT From Hims/Hers?! The recent withdrawal of Hims

MOUNJARO is the proprietary brand name Eli Lilly uses for it across applicable markets and strengths.[1][5] MOUNJARO is therefore tirzepatide, and tirzepatide is the same molecule present in every MOUNJARO presentation from 2.5mg through 15mg the names describe the same therapeutic agent, though they are not interchangeable regulatory designations in every jurisdiction.[5] In the U.S., tirzepatide is marketed as MOUNJARO for type 2 diabetes and as Zepbound for chronic weight management

Originally developed to manage type 2 diabetes, these medications have shown powerful effects on appetite regulation and body weight

and systemic inflammatory conditions, where BPC-157s multisystemic anti-inflammatory profile could prove particularly relevant

JAMA Opththamol 2013

They belong to completely different categories: Phentermine = stimulant appetite suppressant GLP-1 = hormone-based metabolic treatment Which One Should You Choose

There have also been some recent reports that they might be linked to gastroparesis in some patients